News
DynaCAD urology with advanced annotation UroNav cart with advanced annotation option UroNav with advanced annotation July 23, 2025 Supporting prostate cancer diagnosis with more precise guidance for ...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options ...
Androgen deprivation therapy (ADT) has long been a foundation in the management of prostate cancer. Since the introduction of ...
Finding cancer early makes it much more likely that treatment will work. There are early signs of cancer that are easy to ...
A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...
ArteraAI Prostate analyzes digital pathology images of a prostate cancer biopsy slide to help clinicians predict long-term outcomes.
Hyundai ADM Bio said Monday that it is working on a new drug, Penetrium, which is intended to help enhance the efficiency of ...
Research confirms that many men with nonmetastatic prostate cancer will not die of their disease once they received recommended treatment.
A phase 2 trial shows promising safety results for carotuximab in treating advanced prostate cancer, offering hope for ...
Prostate cancer is one of the most common cancers in men in the United States. While one in nine men will be diagnosed with ...
Cubs legend and Baseball Hall of Fame member Ryne Sandberg provided an update on health Wednesday morning in a statement ...
Prostate cancer focal therapies include cryotherapy, irreversible electroporation ablation (IRE), & high-intensity focused ultrasound (HIFU).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results